Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 5 x 100 µg
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Neurodegenerative Diseases
- 50-100 Tests
- AChE - Neurodegenerative Diseases
- ACP-196
- ACP196
- Adenosine Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Neurodegenerative Diseases
- adu-s100
- adus100
- AMPA - Neurodegenerative Diseases
- Amphibian peptides and Hormones
- AMPK - Neurodegenerative Diseases
- Anti-ulceratives and Antacids
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antimicrobial - Peptides
- Antimicrobial Peptides - Microbiology
- Antimicrobial Peptides - Natural Products
- Antimicrobial Peptides - Others
- Arthropod peptides and Hormones
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- BACE1
- BAY1816032
- BChE - Neurodegenerative Diseases
- BIX01294
- BUB1
- BYL719
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- CEP-28122
- chemicals for COVID-19 research
- CHIR99021
- Chk1/2
- COMT - Neurodegenerative Diseases
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- CYP17A1 Inhibitors
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptors - Neurodegenerative Diseases
- D3 Receptors - Neurodegenerative Diseases
- D4 Receptors - Neurodegenerative Diseases
- DA Receptor Signaling - Neurodegenerative Diseases
- DAT - Neurodegenerative Diseases
- DOT1L Histone Methyltransferase
- eidd-1931
- EIDD-2801
- EIDD2801
- eIF2B - Neurodegenerative Diseases
- Fast Skeletal Muscle Troponin Complex - Neurodegenerative Diseases
- GABA - Neurodegenerative Diseases
- Gamma Secretase - Neurodegenerative Diseases
- Gastric Inhibitory Peptide
- Gastrin-releasing Peptide
- GBR-12935
- GDC-0941
- GLP-1 Agonists
- glycopeptides
- GSK-429286A
- HEXIM1
- HIF-1
- Histamine Receptors - Neurodegenerative Diseases
- IGF-1R
- Imidazoline Receptors - Neurodegenerative Diseases
- Ion Channels - Neurodegenerative Diseases
- JQ-1
- JQ-1
- K+ Ion Channels - Neurodegenerative Diseases
- KNL1
- Kynurenine 3-hydroxylase - Neurodegenerative Diseases
- loratadine
- LOXO-195
- loxo195
- LRRK2 - Neurodegenerative Diseases
- mAChR - Neurodegenerative Diseases
- MAO - Neurodegenerative Diseases
- Melatonin Receptors - Neurodegenerative Diseases
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR - Neurodegenerative Diseases
- Natural Products
- neratinib
- NET - Neurodegenerative Diseases
- Neurodegenerative Diseases
- New Products
- Nitrates
- NK - Neurodegenerative Diseases
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA Receptors - Neurodegenerative Diseases
- NSAIDs: COX-1 Inhibitors
- Opioid Peptide Agonists
- Opioid Receptors - Neurodegenerative Diseases
- Other DA Signaling - Neurodegenerative Diseases
- Other Products
- OTX-015
- p110
- p110alpha
- P2Y12
- Pancreatic Polypeptide
- Parathyroid Hormone Agonists
- PDK1
- Peptide Neurotransmitters
- peptide YY
- Peptides
- PF-07321332
- Pim-1
- Pim1
- PKC412
- PPAR Agonists (Fibrates)
- Prolactin-releasing Peptide Agonists
- Prolyl Oligopeptidase - Neurodegenerative Diseases
- Rac1
- RAD51
- rated-1
- rated-2
- rated-3
- rated-4
- rated-5
- RN-1734
- ROS1
- SB-431542
- ser910
- Serotonin Receptors - Neurodegenerative Diseases
- SERT - Neurodegenerative Diseases
- Sigma Receptors - Neurodegenerative Diseases
- SIRT - Neurodegenerative Diseases
- su9516
- T315i
- TAK-931
- Therapies for Respiratory Diseases and Allergy Management
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Neurodegenerative Diseases
- UNC0064-12
- VE821
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- β Cell Proliferation Activator
Product Matches
- A4854β-Amyloid Peptide (1-42), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4851β-Amyloid Peptide (1-40), rat
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4853β-Amyloid Peptide (1-42), human
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4852β-Amyloid Peptide (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- P2833Peptide Histidine Isoleucine, rat
Endogenous peptide hormone; VPAC2 activator.
≥95% - P1768Peptide YY (3-36), human
Endogenous neuropeptide fragment, involved in enteric movement and feeding be...
≥95% - P1762Peptide YY, porcine
Endogenous neuropeptide, involved in enteric movement and feeding behavior; Y...
≥98% - P1763Peptide YY, human
Endogenous neuropeptide, involved in enteric movement and feeding behavior; Y...
≥98% - G0181Gastrin Releasing Peptide, human
Endogenous bombesin-like peptide, involved in feeding behavior, stress signal...
≥95% - A5460A-type Natriuretic Peptide (1-11), rat
Endogenous cardiomodulatory peptide; NPR-A agonist.
≥95% - P6850Prolactin-Releasing Peptide (1-31), human
Endogenous peptide hormone, involved in hormone secretion; GPR10 agonist.
≥98% - A7669A-type Natriuretic Peptide (1-28), rat
Endogenous cardiomodulatory peptide; NPR-A agonist.
≥95% - G0175Gastric Inhibitory Peptide, human
Endogenous peptide hormone, somatostatin analog; GIP-R agonist.
≥95% - A4849Amyloid-β (25-35)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥95% - A4848Amyloid-β (1-40)
Endogenous APP peptide cleavage product, primary component in amyloid plaques...
≥98% - P0011Pituitary Adenylate Cyclase-activating Polypeptide-related Peptide, rat
Peptide, involved in paracrine and autocrine cell signaling; PAC1 and VPAC1/2...
≥95% - B5560B-type Natriuretic Peptide (1-32), rat
Endogenous cardiomodulatory peptide; NPR-A agonist.
≥95% - C5260C-type Natriuretic Peptide (1-22), pig/human/rat
Endogenous cardiomodulatory peptide; NPR-B agonist.
≥95% - G4485[Ala19]-Glucagon-like Peptide II, rat
Peptide hormone, GLP-2 derivative; GLP2 agonist.
≥95%